Δονεπεζίλη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Δονεπεζίλη" in Greek language version.

refsWebsite

Global rank Greek rank

14nih.gov

4^th place

7doi.org

2^nd place

3^rd place

4web.archive.org

1^st place

2worldcat.org

5^th place

8^th place

2clincalc.com

3,912^th place

594^th place

2fda.gov

447^th place

368^th place

1erx.gr

low place

2,875^th place

1drugs.com

399^th place

130^th place

1medicaid.gov

low place

9,694^th place

1nice.org.uk

3,258^th place

2,509^th place

1medlineplus.gov

1,581^st place

474^th place

1bucksformulary.nhs.uk

low place

bucksformulary.nhs.uk

«Table 4. NHS Guideline» (PDF). σελ. 6 of 11. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 31 Δεκεμβρίου 2019. Re-titration following AChEI missed doses or planned treatment breaks

clincalc.com

«The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.
«Donepezil Hydrochloride – Drug Usage Statistics». ClinCalc. Αρχειοθετήθηκε από το πρωτότυπο στις 8 Ιουλίου 2020. Ανακτήθηκε στις 11 Απριλίου 2020.

doi.org

dx.doi.org

Seltzer, Ben (2005-09-29). «Donepezil: a review». Expert Opinion on Drug Metabolism & Toxicology (Informa Healthcare) 1 (3): 527–36. doi:10.1517/17425255.1.3.527. ISSN 1742-5255. PMID 16863459. «there is a linear relationship between dose and pharmacodynamic effects, measured as red blood cell acetylcholinesterase inhibition and clinical efficacy. Despite being 96% bound to plasma proteins, it has few interactions with other drugs, and the 5-mg dose can be given safely to patients with mild-to-moderate hepatic and renal-disease.».
«Donepezil for dementia due to Alzheimer's disease». The Cochrane Database of Systematic Reviews 6: CD001190. June 2018. doi:10.1002/14651858.CD001190.pub3. PMID 29923184.
«Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease». Clinical Pharmacokinetics 52 (4): 225–41. April 2013. doi:10.1007/s40262-013-0038-9. PMID 23408070.
«Selective loss of central cholinergic neurons in Alzheimer's disease». Lancet 2 (8000): 1403. December 1976. doi:10.1016/s0140-6736(76)91936-x. PMID 63862.
«The cholinergic system in Alzheimer's disease». Progress in Neurobiology 52 (6): 511–35. August 1997. doi:10.1016/s0301-0082(97)00028-2. PMID 9316159.
«The pharmacology of sigma-1 receptors». Pharmacology & Therapeutics 124 (2): 195–206. November 2009. doi:10.1016/j.pharmthera.2009.07.001. PMID 19619582.

doi.org

Asiri, Yousif A.· Mostafa, Gamal A.E. (2010). «Donepezil». Profiles of Drug Substances, Excipients and Related Methodology. 35. Elsevier. σελίδες 117–50. doi:10.1016/s1871-5125(10)35003-5. ISBN 978-0-12-380884-4. ISSN 1871-5125. PMID 22469221. Plasma donepezil concentrations decline with a half-life of approximately 70 h. Sex, race, and smoking history have no clinically significant influence on plasma concentrations of donepezil [46–51].

drugs.com

«Donepezil Hydrochloride Monograph for Professionals». Drugs.com (στα Αγγλικά). American Society of Health-System Pharmacists. Ανακτήθηκε στις 4 Φεβρουαρίου 2019.

erx.gr

https://erx.gr/p/z/?type=pl&bcode=2802953502017

fda.gov

«FDA Approves Expanded Use of Treatment for Patients With Severe Alzheimer's Disease». FDA. 2006-10-13. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-07-10. https://web.archive.org/web/20090710031727/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108768.htm.

accessdata.fda.gov

«www.accessdata.fda.gov» (PDF).

medicaid.gov

data.medicaid.gov

«NADAC as of 2019-01-30». Centers for Medicare and Medicaid Services (στα Αγγλικά). Αρχειοθετήθηκε από το πρωτότυπο στις 27 Μαρτίου 2019. Ανακτήθηκε στις 4 Φεβρουαρίου 2019. 0.04978 (per tablet)

medlineplus.gov

«Donepezil: MedlinePlus Drug Information». MedlinePlus. 22 Δεκεμβρίου 2019. Ανακτήθηκε στις 31 Δεκεμβρίου 2019. If you forget to take a dose of donepezil, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one. If you do not take donepezil, for 1 week or longer, you should call your doctor before starting to take this medication again.

nice.org.uk

«Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease | Guidance and guidelines | NICE». www.nice.org.uk. 23 Μαρτίου 2011. Ανακτήθηκε στις 4 Φεβρουαρίου 2019.

nih.gov

ncbi.nlm.nih.gov

Kumar, A; Sharma, S (2020), «article-20656», Donepezil, Treasure Island (FL): StatPearls Publishing, PMID 30020629, http://www.ncbi.nlm.nih.gov/books/NBK513257/, ανακτήθηκε στις 2020-04-12
Seltzer, Ben (2005-09-29). «Donepezil: a review». Expert Opinion on Drug Metabolism & Toxicology (Informa Healthcare) 1 (3): 527–36. doi:10.1517/17425255.1.3.527. ISSN 1742-5255. PMID 16863459. «there is a linear relationship between dose and pharmacodynamic effects, measured as red blood cell acetylcholinesterase inhibition and clinical efficacy. Despite being 96% bound to plasma proteins, it has few interactions with other drugs, and the 5-mg dose can be given safely to patients with mild-to-moderate hepatic and renal-disease.».
Asiri, Yousif A.· Mostafa, Gamal A.E. (2010). «Donepezil». Profiles of Drug Substances, Excipients and Related Methodology. 35. Elsevier. σελίδες 117–50. doi:10.1016/s1871-5125(10)35003-5. ISBN 978-0-12-380884-4. ISSN 1871-5125. PMID 22469221. Plasma donepezil concentrations decline with a half-life of approximately 70 h. Sex, race, and smoking history have no clinically significant influence on plasma concentrations of donepezil [46–51].
«Donepezil for dementia due to Alzheimer's disease». The Cochrane Database of Systematic Reviews 6: CD001190. June 2018. doi:10.1002/14651858.CD001190.pub3. PMID 29923184.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654795/
Swedish Council on Health Technology Assessment (June 2008). Dementia – Caring, Ethics, Ethnical and Economical Aspects: A Systematic Review. PMID 28876770.
«Is donepezil effective for treating Alzheimer's disease?». Canadian Family Physician 45: 917–19. April 1999. PMID 10216789.
«Pharmacodynamic, pharmacokinetic and pharmacogenetic aspects of drugs used in the treatment of Alzheimer's disease». Clinical Pharmacokinetics 52 (4): 225–41. April 2013. doi:10.1007/s40262-013-0038-9. PMID 23408070.
«Selective loss of central cholinergic neurons in Alzheimer's disease». Lancet 2 (8000): 1403. December 1976. doi:10.1016/s0140-6736(76)91936-x. PMID 63862.
«The cholinergic system in Alzheimer's disease». Progress in Neurobiology 52 (6): 511–35. August 1997. doi:10.1016/s0301-0082(97)00028-2. PMID 9316159.
«The pharmacology of sigma-1 receptors». Pharmacology & Therapeutics 124 (2): 195–206. November 2009. doi:10.1016/j.pharmthera.2009.07.001. PMID 19619582.

pubmedcentral.nih.gov

«Donepezil for dementia due to Alzheimer's disease». The Cochrane Database of Systematic Reviews 6: CD001190. June 2018. doi:10.1002/14651858.CD001190.pub3. PMID 29923184.
«Is donepezil effective for treating Alzheimer's disease?». Canadian Family Physician 45: 917–19. April 1999. PMID 10216789.
«The pharmacology of sigma-1 receptors». Pharmacology & Therapeutics 124 (2): 195–206. November 2009. doi:10.1016/j.pharmthera.2009.07.001. PMID 19619582.

web.archive.org

«NADAC as of 2019-01-30». Centers for Medicare and Medicaid Services (στα Αγγλικά). Αρχειοθετήθηκε από το πρωτότυπο στις 27 Μαρτίου 2019. Ανακτήθηκε στις 4 Φεβρουαρίου 2019. 0.04978 (per tablet)
«Donepezil Hydrochloride – Drug Usage Statistics». ClinCalc. Αρχειοθετήθηκε από το πρωτότυπο στις 8 Ιουλίου 2020. Ανακτήθηκε στις 11 Απριλίου 2020.
«FDA Approves Expanded Use of Treatment for Patients With Severe Alzheimer's Disease». FDA. 2006-10-13. Αρχειοθετήθηκε από το πρωτότυπο στις 2009-07-10. https://web.archive.org/web/20090710031727/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108768.htm.
«Table 4. NHS Guideline» (PDF). σελ. 6 of 11. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 31 Δεκεμβρίου 2019. Re-titration following AChEI missed doses or planned treatment breaks

worldcat.org

Seltzer, Ben (2005-09-29). «Donepezil: a review». Expert Opinion on Drug Metabolism & Toxicology (Informa Healthcare) 1 (3): 527–36. doi:10.1517/17425255.1.3.527. ISSN 1742-5255. PMID 16863459. «there is a linear relationship between dose and pharmacodynamic effects, measured as red blood cell acetylcholinesterase inhibition and clinical efficacy. Despite being 96% bound to plasma proteins, it has few interactions with other drugs, and the 5-mg dose can be given safely to patients with mild-to-moderate hepatic and renal-disease.».
Asiri, Yousif A.· Mostafa, Gamal A.E. (2010). «Donepezil». Profiles of Drug Substances, Excipients and Related Methodology. 35. Elsevier. σελίδες 117–50. doi:10.1016/s1871-5125(10)35003-5. ISBN 978-0-12-380884-4. ISSN 1871-5125. PMID 22469221. Plasma donepezil concentrations decline with a half-life of approximately 70 h. Sex, race, and smoking history have no clinically significant influence on plasma concentrations of donepezil [46–51].